Bullfrog AI (BFRG) vs Vyome (HIND)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Bullfrog AI (BFRG) has outperformed Vyome (HIND) over the past year, losing 52.4% versus a loss of 65.4%. Vyome is the larger company by market cap ($14.2 million vs $12.8 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BFRG | HIND |
|---|---|---|
| Share price | $0.6924 | $2.03 |
| Market cap | $12.84M | $14.25M |
| 1-day change | -2.29% | -0.49% |
| YTD return | -19.75% | -40.99% |
| 1-year return | -52.44% | -65.42% |
| 5-year return | — | -100.00% |
| P/E ratio (TTM) | — | 1.14 |
| EPS (TTM) | $-0.46 | $1.78 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $1.96 | $6.56 |
| 52-week low | $0.425 | $1.75 |
| Distance from 52-week high | -64.67% | -69.05% |
| Average volume | 5.32M | 13.60K |
| Shares outstanding | 18.54M | 7.02M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- BFRG has outperformed HIND by 13.0 percentage points over the past year.
BFRG vs HIND FAQ
Which is bigger, Bullfrog AI or Vyome?
Vyome (HIND) is larger, with a market capitalization of $14.25M compared with $12.84M for Bullfrog AI (BFRG).
Which stock has performed better over the past year, BFRG or HIND?
BFRG returned -52.44% over the past 12 months, compared with -65.42% for HIND (price return, excluding dividends). Past performance does not predict future results.
Are Bullfrog AI and Vyome in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.